Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Express Scripts
Boehringer Ingelheim
Mallinckrodt

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Small Molecule Drugs cited in Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-04-21 1 Cover Sheet US Patent No. 8,362,069, # 2 Exhibit(s) B - US Patent No. 8,815,816, # 3 Exhibit(s) C - US Patent No.…9,089,587, # 4 Exhibit(s) D - US Patent No. 9,233,117, # 5 Exhibit(s) E - US Patent No. 9,233,118, # 6 Cover …11 December 2017 1:17-cv-01783-RGA Patent Plaintiff District Court, D. External link to document
2018-09-07 124 argues for a construction drawn from U.S . Patent No . 6,133,310 ("Parks"), which is incorporated… six patents from three patent families against Defendant. (D.I. 110 at 1). The ' 587 Patent, the…the ' 117 Patent, the ' 118 Patent, and the '425 Patent are members of the Jacovella … history of the '249 Patent, a patent extrinsic to the ' 069 Patent, provides at least some support…of multiple terms in U.S. Patent Nos. 8,815,816 (the "' 816 Patent"), 8,362,069 (the " External link to document
2019-08-21 257 Opinion - Memorandum Opinion related to U.S. Patent Nos. 8,362,069 ("the ' 069 patent"), 8,815,816 ("the ' … the case to three patents-U.S. Patent Nos. 9,089,587 ("the ' 587 patent"), 9,233 ,117 …587 patent, claim 3 of the ' 117 patent, and claim 11 of the ' 118 patent each…117 ("the' 117 patent"), and 9,233 ,118 ("the ' 118 patent") (collectively,…the asserted patents. Galderma asserts infringement of claim 12 of the ' 587 patent, claims 2, 3, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.